Mapping HIV-linked infections unearths diagnosis 'blank spots' in Africa
A map of deadly infectious diseases known to attack the central nervous system (CNS) of people who are already suffering with ...
HOOKIPA Pharma Announces Enrollment Completion of Phase 1b Clinical Trial Evaluating HB-500 for the Treatment of HIV
HB-500 is a next-generation therapeutic vaccine being developed in collaboration with Gilead Sciences, Inc. (Gilead) as a potential component of ...